Literature DB >> 32684411

Genetic polymorphisms of proteasome subunit genes of the MHC-I antigen-presenting system are associated with cervical cancer in a Chinese Han population.

Chuanyin Li1, Shuying Dai2, Zhiling Yan3, Xinwen Zhang1, Shuyuan Liu1, Xia Wang3, Jun Wang3, Li Shi4, Yufeng Yao5.   

Abstract

Proteasome subunit beta types 8 and 9 (PSMB8, PSMB9) play critical roles in the human leukocyte antigen class I (HLA I)-presenting system. Studies have suggested that polymorphisms in the PSMB8 and PSMB9 genes may influence the immune functions of PSMB8 and PSMB9, and thus be associated with various human cancers. We investigated associations involving single nucleotide polymorphisms (SNPs) rs2071543 in PSMB8, rs1351383, rs17587 and rs2127675 in PSMB9 and risk of cervical intraepithelial neoplasia (CIN) and cervical cancer in a Chinese Han population. A total of 543 patients with CIN, 1008 patients with cervical cancer, and 1120 healthy individuals were enrolled. Agena MassArray was used for SNP genotyping of PSMB8 and PSMB9. Associations involving these SNPs and risk of CIN and cervical cancer were analysed. Our results showed that the PSMB8 T/T and T/G genotypes of rs2071543 may be associated with a higher risk of CIN (P = 0.011, OR = 1.35,95% CI: 1.07-1.70) and cervical cancer (P = 0.006, OR = 1.31, 95% CI: 1.08-1.59). For rs17587, the A allele (P = 0.001, OR = 1.303, 95% CI: 1.115-1.522), and the A/A and A/G genotypes (P = 0.001, OR = 1.36, 95% CI: 1.13-1.63) may be risk factors for cervical cancer. These results indicated that PSMB8 rs2071543 might influence susceptibility to CIN and cervical cancer, and PSMB9 rs17587 might influence cervical cancer susceptibility in a Chinese Han population.
Copyright © 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Association; CIN; Cervical cancer; Chinese Han population; PSMB8 and PSMB9 genes; Single nucleotide polymorphisms

Mesh:

Substances:

Year:  2020        PMID: 32684411     DOI: 10.1016/j.humimm.2020.07.002

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Bioinformatic Analysis Identifying PSMB 1/2/3/4/6/8/9/10 as Prognostic Indicators in Clear Cell Renal Cell Carcinoma.

Authors:  Jing-Yi Guo; Zuo-Qian Jing; Xue-Jie Li; Li-Yuan Liu
Journal:  Int J Med Sci       Date:  2022-05-01       Impact factor: 3.642

2.  Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis.

Authors:  Wanda Niepiekło-Miniewska; Łukasz Matusiak; Joanna Narbutt; Alekandra Lesiak; Piotr Kuna; Andrzej Wiśniewski; Piotr Kuśnierczyk
Journal:  Life (Basel)       Date:  2021-04-10

3.  Integrated genomic analysis of proteasome alterations across 11,057 patients with 33 cancer types: clinically relevant outcomes in framework of 3P medicine.

Authors:  Na Li; Xianquan Zhan
Journal:  EPMA J       Date:  2021-09-30       Impact factor: 6.543

4.  Transcriptome Analysis Reveals Possible Immunomodulatory Activity Mechanism of Chlorella sp. Exopolysaccharides on RAW264.7 Macrophages.

Authors:  Siwei Wu; Hongquan Liu; Siyu Li; Han Sun; Xiumiao He; Ying Huang; Han Long
Journal:  Mar Drugs       Date:  2021-04-14       Impact factor: 5.118

5.  Genetic Polymorphisms in microRNA Genes Targeting PI3K/Akt Signal Pathway Modulate Cervical Cancer Susceptibility in a Chinese Population.

Authors:  Kerong Chen; Zhiling Yan; Xudong Dong; Yan Liang; Yueting Yao; Shao Zhang; Weipeng Liu; Chuanyin Li; Yufeng Yao; Li Shi
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

Review 6.  The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer.

Authors:  Satyendra Chandra Tripathi; Disha Vedpathak; Edwin Justin Ostrin
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.